SCHEMBL7367112

SCHEMBL7367112

CC(C)CC1(C(=O)O)CCCCC(=N)C1

nearest known ligand 0.37

Predicted protein targets (top 4)

geneUniProtsupporting neighboursconfidence
CYP2C19 P33261 1/20 0.37
MME P08473 8/20 0.36
LTA4H P09960 1/20 0.31
CETP P11597 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1837779 0.79 CYP2C19 (0.50) CYP2C19MMELTA4HCETP
SCHEMBL5512489 0.77 CYP2C19 (0.54) CYP2C19MMELTA4HCETP
SCHEMBL12308361 0.75 CYP2C19 (0.45) CYP2C19MMELTA4H
SCHEMBL5728858 0.73 HDAC1 (0.33)
SCHEMBL4984867 0.72 CPB2 (0.32)
SCHEMBL10900629 0.71 CYP2C19 (0.38) CYP2C19MME
SCHEMBL8847977 0.69 CYP2C19 (0.38) CYP2C19MMELTA4HCETP
SCHEMBL6382992 0.67 HDAC1 (0.33)
SCHEMBL14417093 0.66 CYP2C19 (0.39) CYP2C19MMELTA4HCETP
SCHEMBL11381051 0.65 CYP2C19 (0.38) CYP2C19MMELTA4HCETP

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6117841-A USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY WARNER-LAMBERT COMPANY (US) 2000-09-12 US claimed
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO claimed
US-6117841-A USED TO TREAT STROKE, CEREBRAL ISCHEMIA, PAIN, HEAD TRAUMA OR EPILEPSY WARNER-LAMBERT COMPANY (US) 2000-09-12 US disclosed
WO-1998054123-A1 SUBSTITUTED PEPTIDYLAMINE CALCIUM CHANNEL BLOCKERS WARNER-LAMBERT COMPANY (US) 1998-12-03 WO disclosed